Home » Prices » NASDAQ:ICPT

Intercept Pharmaceuticals, Inc. NASDAQ:ICPT

Today's live share price, quote history, chart & news

Price:
41.90 USD
Change:
-1.72 (-3.94%)
Key Stats
Price open 43.97
Previous close 43.62
Market cap 1.38B
Volume 1.26M
Day high 43.97
Day low 41.4
Year high 125
Year low 40.3
Year to date change -67.19%
P/E Ratio -4.04
Company Profile
Fundamentals
Insider Information
News

About Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

Company information

Company name
Intercept Pharmaceuticals, Inc.
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Other
Employees
583
CEO
Mark E. Pruzanski
Address
10 Hudson Yards, New York, NY, 10001
Country
United States
Contact information
1.646.747.1000
Website
http://www.interceptpharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.